AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares

Group 1 - AngioDynamics has a less-than-ideal track record and faces ongoing challenges in its slow-growing legacy operations [1] - Despite these challenges, there is a bullish outlook on AngioDynamics stock due to better results in the growth-oriented Medical Tech segment [1]